BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2019 1:54:18 AM | Browse: 14 | Download: 20
Publication Name World Journal of Gastrointestinal Pathophysiology
Manuscript ID 48680
Country of Manuscript Source Japan
Received
2019-04-28 01:54
Peer-Review Started
2019-05-09 02:21
To Make the First Decision
2019-06-13 02:13
Return for Revision
2019-06-17 03:32
Revised
2019-06-30 23:56
Second Decision
2019-08-21 03:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-08-21 18:54
Articles in Press
2019-08-21 18:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-09-05 03:54
Publish the Manuscript Online
2019-09-09 01:54
ISSN 2150-5330 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript type Minireviews
Article Title Immune checkpoint inhibitor-induced diarrhea/colitis: Endoscopic and pathologic findings
Manuscript Source Invited Manuscript
All Author List Tsutomu Nishida, Hideki Iijima and Shiro Adachi
ORCID
Author(s) ORCID Number
Tsutomu Nishida http://orcid.org/0000-0003-4037-9003
Hideki Iijima http://orcid.org/0000-0002-5423-3059
Shiro Adachi http://orcid.org/0000-0001-6159-1682
Funding Agency and Grant Number
Correspondence To Tsutomu Nishida, MD, PhD, Doctor, Department of Gastroenterology, Toyonaka Municipal Hospital, 4-14-1 Shibahara, Toyonaka, Osaka 560-8565, Japan. tnishida.gastro@gmail.com
Keywords Immune checkpoint inhibitor; Colitis; Diarrhea; Endoscopic; Pathologic;
Core Tip Immune checkpoint inhibitor (ICPI)-induced colitis/diarrhea is frequent and recognized not only by oncologists but also by gastroenterologists or endoscopists. The endoscopic findings resemble those of inflammatory bowel disease to a certain extent, particularly ulcerative colitis, but are not identical. The pathological findings of ICPI-induced colitis may vary among drug classes. The findings show acute or chronic phases but may depend on the diagnostic timing or treatment intervention. Colonoscopy with biopsy is necessary to confirm ICPI-induced colitis, and early evaluation may avoid exacerbating or prolonging colitis due to treatment resistance.
Publish Date 2019-09-09 01:54
Citation Nishida T, Iijima H, Adachi S. Immune checkpoint inhibitor-induced diarrhea/colitis: Endoscopic and pathologic findings. World J Gastrointest Pathophysiol 2019; 10(2): 17-28
Url https://www.wjgnet.com/2150-5330/full/v10/i2/17.htm
DOI https://dx.doi.org/10.4291/wjgp.v10.i2.17
Full Article (PDF) WJGP-10-17.pdf
Manuscript File 48680-Review.docx
Answering Reviewers 48680-Answering reviewers.pdf
Audio Core Tip 48680-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 48680-Conflict-of-interest statement.pdf
Copyright License Agreement 48680-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 48680-Language certificate.pdf
Peer-review Report 48680-Peer-review(s).pdf
Scientific Misconduct Check 48680-Scientific misconduct check.pdf
Scientific Editor Work List 48680-Scientific editor work list.pdf